Displaying One Session

Time
11:00 AM - 12:30 PM

All Presentations (ID 1971)

Welcome (ID 1846)

Present and future of molecular testing in lung cancer (ID 1847)

Evolving ALK + NSCLC paradigm (ID 1848)

Optimal sequencing strategies in second line and beyond (ID 1849)

Conclusion (ID 1850)